Chromadex Stock Price (NASDAQ:CDXC)

Add to My Stocks
$5.12 $0.06 (1.19%) CDXC stock closing price Feb 21, 2018 (Closing)
Prev Close* : $5.06
Market Cap:
$272.42M
Day Low: $5.04
52 Week Low: $2.26
Open: $5.1
Volume: -
Day High: $5.26
52 Week High: $7.24
Dividend:
0.00

Latest Stock Market News

Latest Articles

Chromadex News - From Partners

CDXC Stockcharts

View CDXC PE ratio, PS ratio stocks charts and compare with peers.
CDXC Chart
Note: Compare Chromadex stock price history with the index and industry peers.

Chromadex Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
11.21
PB ratio (
price to book ratio
)
13.3

Chromadex Returns

ROE
(return on equity)
-26%

Chromadex Financial Ratios

Asset Turnover
0.65
Receivables Turnover
4
Debt to Equity
0.02
Dividend Yield
0%

CDXC Industry Peers

Company Price Change (%)
Mustang Bio Inc (MBIO)11.050.19 (1.75%)
Viking Therapeutics (VKTX)6.820.38 (5.9%)
Cellular Dynamics (ICEL)16.550.03 (0.18%)
Repligen (RGEN)32.40.64 (2.02%)
Pathfinder Cell (PFND)00 (0%)
Illumina (ILMN)227.911.34 (0.59%)
Prodite Pharma (PPMD)0.040 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Fate Therapeutics (FATE)10.591.42 (15.49%)
NeoGenomics (NEO)8.080.72 (9.78%)
Sunesis Pharma (SNSS)6.990.62 (9.73%)
Compugen (CGEN)3.250.2 (6.56%)
Fortress Biotech (FBIO)3.630.21 (6.14%)
Alder BioPharma (ALDR)14.550.7 (5.05%)
Stemline Therapeutics (STML)16.550.75 (4.75%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018
CompanyPriceChange (%)
GTx (GTXI)15.461.25 (7.48%)
Catalyst Biosciences (CBIO)27.541.96 (6.64%)
Five Prime Therapeutics (FPRX)17.681.21 (6.41%)
Arbutus Biopharma (ABUS)5.250.25 (4.55%)
Ultragenyx Pharma (RARE)46.311.87 (3.88%)
MediciNova (MNOV)10.610.4 (3.63%)
The Medicines Company (MDCO)31.621.18 (3.6%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 22, 2018

Chromadex Corp Stock News - Partner Headlines

Chromadex Financial Statements

income statement20162015201420132012
Net Sales or Revenues26.81M22.01M15.31M10.16M11.61M
Net Income-2.92M-2.77M-5.38M-4.41M-11.66M
Total Operating Expense14.16M9.74M10.46M7.42M13.91M
View Chromadex income statement
balance sheet20162015201420132012
Total Assets19.75M18.74M11.6M8.98M9.03M
Total Liabilities9.77M13.47M7.6M3.32M5.04M
Shareholders Equity9.97M5.27M3.99M5.66M3.99M
View Chromadex balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-2.76M-2.2M-0.48M-1.15M-1.5M
Net Cash from (used by) Operating Activities-2.93M-2.11M-2.58M-3.9M-10.11M
Increase (Decrease) in Prop Plant And Equipment-1.5M-0.52M-0.12M--0.02M
View Chromadex cash flow statement

Chromadex Stock Message Board

Chromadex stock price ended the last trading day at $5.12. Stock price or share price can be used to find the total market value of a company. Chromadex market cap stands at $272.42M as of Feb 21, 2018. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Chromadex stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Chromadex is worth a lot, it will most likely be reflected in an inflated Chromadex stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 363,326 shares were traded with a closing stock price of $5.12 as of Feb 21, 2018, as can be seen from Chromadex stock quote. One can view Chromadex stock chart to follow the stock price trend. Chromadex paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of CDXC, view Chromadex stock price history.